New Drug Approvals Archive

Get news by email or subscribe to our news feeds.

November 2003

November 21

Climara Pro (estradiol and levonorgestrel ) Transdermal System

Date of Approval: November 21, 2003
Company: Berlex Laboratories
Treatment for: Postmenopausal Symptoms

Climara Pro (estradiol and levonorgestrel) is a transdermal combined hormone therapy for the relief of moderate to severe vasomotor symptoms associated with menopause, such as hot flashes and night sweats.

November 21

Cialis (tadalafil) Tablets

Date of Approval: November 21, 2003
Company: Eli Lilly and Co.
Treatment for: Erectile Dysfunction, Benign Prostatic Hyperplasia

Cialis is a phosphodiesterase 5 (PDE5) inhibitor indicated for erectile dysfunction, and to treat the signs and symptoms of benign prostatic hyperplasia.

November 21

Climara Pro (estradiol and levonorgestrel ) Transdermal System

Date of Approval: November 21, 2003
Company: Berlex Laboratories
Treatment for: Postmenopausal Symptoms

Climara Pro (estradiol and levonorgestrel) is a transdermal combined hormone therapy for the relief of moderate to severe vasomotor symptoms associated with menopause, such as hot flashes and night sweats.

January 8

Cialis (tadalafil)

New Dosage Regimen: January 7, 2008

October 6

Cialis (tadalafil)

New Indication Approved: October 7, 2011

Hide
(web1)